Nano-toxicology and respiratory toxicology

As regulatory frameworks develop for the nanotechnology industry, we have developed a broad platform of in vitro and in vivo models for designing and conducting investigative and mechanistic safety assessment programmes. These can be used to compare likely toxicological risk across research compounds/formulations, assist in the better design of formal safety studies and assess relevance-to-man of previous adverse findings.

We can help interpret regulatory guidance and design appropriate mechanistic safety studies. We can then explain the mode of action on nanoparticle and respiratory toxicology before assessing its relevance to humans.